Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Improving the Effect of Multiple Sclerosis Drugs by Chronobiology [NA]
A completed clinical trial evaluating whether chronobiology, i.e., drug timing, can improve the effectiveness of multiple sclerosis therapie…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
Clinical trial update indicates that the GentleCath Men intermittent catheter with FeelClean technology has completed its study, evaluating …
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Awareness of Osteoporosis in Multiple Sclerosis Patients
A completed clinical trial assessed awareness of osteoporosis among individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Running Title: Walking to Music and in Silence on a Treadmill [NA]
Clinical trial update for a multiple sclerosis study comparing walking to music versus walking in silence on a treadmill; the trial status i…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Natalizumab and Chronic Inflammation [Phase 4]
Phase 4 clinical trial update for natalizumab in chronic inflammation (multiple sclerosis) has been terminated with results posted in 2024.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients [Phase 4]
Phase 4 trial evaluating the immunogenicity of the recombinant zoster vaccine in patients with multiple sclerosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Time Restricted Eating Outcomes in Multiple Sclerosis [NA]
Completed clinical trial evaluating time-restricted eating effects in individuals with multiple sclerosis; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab [Phase 3]
A Phase 3 trial comparing pretreatment with cetirizine versus diphenhydramine to assess risk and severity of infusion reactions in patients …
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and tolerability of ISX (Isoxsuprine HCL) in multiple sclerosis relapses has completed with…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluating Nabiximols Oromucosal Spray for spasticity in people with multiple sclerosis was terminated; results have been po…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis [Phase 3]
Phase 3 clinical trial evaluating AP707 for chronic pain due to central neuropathy; efficacy and tolerability data are not yet fully disclos…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis [Phase 3]
Open-label Phase 3 extension trial of oral RPC1063 in relapsing multiple sclerosis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRI [NA]
Clinical trial updates on tDCS-induced neuronal responses in multiple sclerosis using advanced MRI; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome [Phase 3]
Phase 3 trial update evaluating vitamin D3 (cholecalciferol) for delaying the diagnosis of multiple sclerosis after a clinically isolated sy…
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients [Phase 4]
Phase 4 trial investigating effects of oral cladribine on remyelination and inflammation in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: MS Spinal Mobilisation Study [NA]
A completed clinical trial evaluating spinal mobilisation for multiple sclerosis, with results posted in early 2024.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis [Phase 2]
Phase 2 trial assessing the safety and efficacy of Elezanumab added to standard of care for relapsing forms of multiple sclerosis; trial com…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating elezanumab added to standard of care in progressive multiple sclerosis has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis [Phase 3]
Phase 3 trial investigating amantadine combined with transcranial magnetic stimulation for fatigue in multiple sclerosis; current status unk…
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Non-invasive Transcranial Electrical Stimulation in MS [NA]
A completed clinical trial investigating non-invasive transcranial electrical stimulation for cognitive impairment in multiple sclerosis, wi…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of monthly long-acting GA Depot IM injection in relapsing-remitting multiple scle…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Phase II Clinical Trial of OCH-NCNP1 [Phase 2]
Phase II clinical trial update for OCH-NCNP1 completed; study conditions include relapsing-remitting and secondary progressive multiple scle…
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Aspirin for Exercise in Multiple Sclerosis (ASPIRE) [Phase 3]
Phase 3 clinical trial ASPIRE evaluating aspirin for exercise benefits in multiple sclerosis has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial evaluating a behavioral modification program in combination with mirabegron to improve urinary urgency in people with…
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Brain Targets in Patients With Bladder Emptying Difficulties [NA]
Clinical trial update with results posted for brain-targeted approaches in patients with neurogenic bladder and multiple sclerosis-related v…